BridgeMD
New treatment option for Opioid Tapering
Official title Opioid Tapering After Hospital Discharge: Testing an Intervention to Improve Post-operative Opioid Prescribing
ClinicalTrials.gov ID: NCT07510373
What this study is testing
- What it's testing
- The investigator team proposes a randomized clinical trial (RCT) to test a discharge opioid taper support ("DOTS") intervention that is embedded in the providers' workflow in the EHR to prompt them to prescribe an opioid taper for patients after orthopedic surgery that is tailored to patients' expected analgesic needs. DOTS includes: 1) a recommendation for a patient-specific opioid taper schedule based on opioid use prior to discharge, 2) an automated discharge opioid prescription based on the recommended taper schedule that providers can override, 3) a patient facing handout and 4) post-discharge telephonic support for patients.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- (Aim 1):
- Age ≥ 18 years
- Any orthopedic surgery during hospitalization
- No pre-operative opioid use (no opioids in EHR in past 1 month)
You likely can't join if
- (Aim 1):
- Opioid Use Disorder [by International Classification of Diseases, 10th revision (ICD-10), in past 6 months}
- Cancer (by ICD-10, in past 6 months)
- Receiving hospice care (by ICD-10, in past 6 months) Inclusion Criteria (Aim 2):
- Meets criteria for inclusion in Aim 1 Exclusion Criteria (Aim 2):
- Not fluent in English
See the full eligibility criteria
- (Aim 1):
- Age ≥ 18 years
- Any orthopedic surgery during hospitalization
- No pre-operative opioid use (no opioids in EHR in past 1 month)
- (Aim 1):
- Opioid Use Disorder [by International Classification of Diseases, 10th revision (ICD-10), in past 6 months}
- Cancer (by ICD-10, in past 6 months)
- Receiving hospice care (by ICD-10, in past 6 months) Inclusion Criteria (Aim 2):
- Meets criteria for inclusion in Aim 1 Exclusion Criteria (Aim 2):
- Not fluent in English
- Do not manage their own medications
- Unable to provide consent over the phone
- Orthopedic surgery due to cancer-related bone disease
- No pre-operative opioid use (no opioids per New York state prescription drug monitoring program in past 1 month)
The study team makes the final eligibility decision.
Where it's taking place
- The Bronx, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include The Bronx, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.